Thrombin-JMI requires no intermediate physiological agent for its action. It activates platelets and catalyzes the conversion of fibrinogen to fibrin, which are essential steps for clot formation.

The JMI administration reiterated its “zero-tolerance” policy towards any form of violence against women, even as a student organisation alleged that the incident took place in full view of ...

JMI Syringes & Medical Devices reported a 234% growth in its net profit during the first nine months of FY2024-25, driven by increased sales and product price hikes. According to its quarterly report ...